Research Article
Immunological and Clinical Characteristics of Systemic Lupus Erythematosus: A Series from Morocco
Table 3
Comparison of the main clinical and immunological features of SLE patients from our series and some countries of MENA region.
| | Manifestations | Our study 2018 | Dubai 2008 [6] | Saudi Arabia 2009 [10] | Oman 2003 [11] | Tunisia 2003 [12] |
| | Number of patients | 50 | 151 | 624 | 73 | 100 | | Mean age (years) | 31.7 | 35.5 | 34.3 | - | 32 | | F:M ratio | 6.1:1 | 20.5:1 | 9.8:1 | 24:1 | 11.5:1 | | Mucocutaneous (%) | 80 | 78.1 | 64.3 | - | - | | Malar rash (%) | 68 | 60.3 | 47.9 | - | 63 | | Photosensitivity (%) | 60 | 43 | 30.6 | - | 53 | | Hematological (%) | 46 | 61.6 | 78 | - | - | | Hemolytic anemia (%) | 16 | 9.9 | 63.1 | - | 6 | | Leucopenia (%) | 8 | 53.6 | 30.1 | 23.5 | - | | Lymphopenia (%) | 30 | - | 40.3 | 49 | 50 | | Thrombocytopenia (%) | 8 | 18.5 | 10.9 | 10.4 | 12 | | Arthritis (%) | 82 | 88.1 | 80.4 | 47.8 | 78 | | Renal involvement (%) | 50 | 51 | 47.9 | 50.7 | 43 | | Neurological involvement (%) | 10 | 15.9 | 27.6 | 33.8 | 25 | | ANA (%) | 88 | 98 | 99.7 | 97 | 100 | | Anti-DNA (%) | 56 | 88.7 | 80.1 | 92 | 56 | | Anti-Sm (%) | 50 | 19.7 | 41.6 | 50 | 61.2 | | Anti-SSA (%) | 38 | 52.3 | 53.1 | 44 | 64 | | Anti-SSB (%) | 10 | 19.8 | 26.1 | 41b | 33.6 |
|
|
P value < 0.05, compared with our data. P value < 0.001, compared with our data. - means not available. |
